文献速递细菌感染、耐药与抗菌药物

2004年至2018年欧洲范围内健康食用动物分离的共生大肠埃希菌抗菌药物耐药性监测

European-wide antimicrobial resistance monitoring in commensal Escherichia coli isolated from healthy food animals between 2004 and 2018.
PubMed 文献 · J Antimicrob Chemother · 2022-01-01

该研究描述了2004-2018年四个时段从屠宰食用动物分离的大肠埃希菌对重要抗菌药物的敏感性。共回收10613株菌,采用CLSI琼脂稀释法集中测定。结论认为共生大肠埃希菌的耐药性因抗生素、动物种类和国家差异很大,对人类医学关键重要抗生素的耐药性缺失或较低,但肉鸡对环丙沙星及猪和肉鸡对氨苄西林的耐药例外。

要点

  • 肉鸡中耐药百分比在最近时段最低(P ≤ 0.01),且多重耐药随时间显著下降,猪呈下降趋势。
  • 对美罗培南和替加环素未检测到耐药,对阿奇霉素耐药为0.2%-2.0%。
  • 肉鸡对环丙沙星耐药为7.3%-23.3%,而牛和猪为0.2%-2.5%;猪和肉鸡对氨苄西林耐药最高达32.7%-65.3%。

核心结论

  • 在这项泛欧盟调查中,共生大肠埃希菌的抗菌药物敏感性因抗生素、动物种类和国家差异很大。
  • 对人类医学关键重要抗生素的耐药性缺失或较低,但肉鸡对环丙沙星及猪和肉鸡对氨苄西林的耐药例外。

研究设计与样本

  • 从牛、猪和肉鸡的肠道内容物中随机采样(每宿主5-6个国家;每国家≥4个屠宰场;每动物/农场一份样本)分离大肠埃希菌。
  • 抗菌药物敏感性由CLSI琼脂稀释法集中测定,采用CLSI临床折点和EUCAST流行病学折点解释数据。
  • 共回收10613株大肠埃希菌,覆盖四个时期:2004-2006、2008-2009、2013-2014、2017-2018。

主要发现

  • 肉鸡中耐药百分比在最近时段最低(P ≤ 0.01),肉鸡多重耐药随时间显著下降,猪呈下降趋势。
  • 对美罗培南和替加环素未检测到耐药,对阿奇霉素耐药为0.2%-2.0%,肉鸡对第三代头孢菌素耐药为1.1%-7.4%。
  • 对黏菌素耐药为0.1%-4.8%;肉鸡对环丙沙星耐药为7.3%-23.3%,牛和猪为0.2%-2.5%。
  • 猪和肉鸡对氯霉素耐药为9.3%-21.3%,对庆大霉素耐药为0.9%-7.0%。
  • 猪和肉鸡对氨苄西林耐药最高为32.7%-65.3%,对四环素为41.3%-67.5%,对甲氧苄啶为32.0%-35.7%,对甲氧苄啶/磺胺甲噁唑为27.5%-49.7%,国家间差异显著。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe the susceptibility of Escherichia coli to medically important antibiotics, collected over four periods (2004-2006, 2008-2009, 2013-2014, 2017-2018), from food-producing animals at slaughter. METHODS: Intestinal contents from cattle, pigs and broilers were randomly sampled (5-6 countries/host; ≥4 abattoirs/country; one sample/animal/farm) for isolation of Escherichia coli; antimicrobial susceptibilities were centrally determined by CLSI agar dilution. Clinical breakpoints (CLSI) and epidemiological cut-off values (EUCAST) were applied for data interpretation. RESULTS: In total, 10 613 E. coli strains were recovered. In broilers, resistance percentages were the lowest (P ≤ 0.01) in the latest time period. A significant decrease in MDR over time was also observed for broilers and a tendency for a decrease for pigs. Resistance to meropenem and tigecycline was absent, and resistance to azithromycin was 0.2%-2.0%. Also, low resistance to third-generation cephalosporins (1.1%-7.4%) was detected in broilers. Resistance to colistin varied between 0.1%-4.8%. E. coli from broilers showed high resistance to ciprofloxacin (7.3%-23.3%), whereas for cattle and pigs this was 0.2%-2.5%. Low/moderate resistance to chloramphenicol (9.3%-21.3%) and gentamicin (0.9%-7.0%) was observed in pigs and broilers. The highest resistance was noted for ampicillin (32.7%-65.3%), tetracycline (41.3%-67.5%), trimethoprim (32.0%-35.7%) and trimethoprim/sulfamethoxazole (27.5%-49.7%) from pigs and broilers, with marked country differences. MDR peaked in pigs and broilers with 24 and 26 phenotypes, with 21.9%-26.2% and 18.7%-34.1% resistance, respectively. CONCLUSIONS: In this pan-EU survey antibiotic susceptibility of commensal E. coli varied largely between antibiotics, animal species and countries. Resistance to critically important antibiotics for human medicine was absent or low, except for ciprofloxacin in broilers and ampicillin in pigs and broilers.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. De Jong A, El Garch F, Hocquet D, et al. European-wide antimicrobial resistance monitoring in commensal Escherichia coli isolated from healthy food animals between 2004 and 2018. J Antimicrob Chemother. 2022. PMID: 36203261. doi:10.1093/jac/dkac318

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。